샘플 요청 목록

 카트 문의
시장보고서
상품코드
1533896

세계의 암로디핀 베실산염 시장

Amlodipine Besylate
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 177 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

암로디핀 베실산염 시장은 2030년까지 13억 달러에 이를 것으로 예상됩니다.

2023년에 12억 달러로 추정된 암로디핀 베실산염 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 2.1%로 성장할 전망이며 2030년에는 13억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 고혈압 애플리케이션은 복합 연간 성장률(CAGR) 2.3%로 성장을 지속하여, 분석 기간이 끝날 때 5억 9,980만 달러에 도달할 것으로 예측됩니다. 심장병 응용 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 2.4%로 추정됩니다.

미국 시장은 3억 1,460만 달러로 추정되며, 중국은 복합 연간 성장률(CAGR) 4.3%로 성장 예측됩니다.

미국의 암로디핀 베실산염 시장은 2023년 3억 1,460만 달러로 추정됩니다. 세계의 2위 경제대국인 중국은 2030년까지 2억 6,130만 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR)은 4.3%입니다. 기타 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 0.5%와 1.5%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 1.0%로 성장할 것으로 예측됩니다.

세계의 암로디핀 베실산염 시장 : 주요 촉진요인과 동향 요약

암로디핀 베실산염은 주로 고혈압(고혈압증)과 협심증(흉통)의 치료에 사용되는 칼슘 채널 차단제입니다. 심근세포나 평활근세포로의 칼슘 이온의 유입을 저해함으로써, 암로디핀 베실산염은 혈관을 이완,확장시키고, 혈류를 개선하고, 심장의 일량을 감소시킵니다. 이 작용기전에 의해 암로디핀 베실산염은 뇌졸중, 심장 발작, 고혈압에 수반하는 기타 심혈관계 질환의 예방에 효과적인 치료제가 됩니다. 암로디핀 베실산염은 1일 1회 경구 정제로 처방되는 경우가 많으며, 단독 또는 다른 벅 약물과 함께 사용할 수 있습니다.

소개 이후, 암로디핀 베실산염의 사용은 현저하게 확장되었으며, 그 효과와 안전성은 많은 연구에 의해 검증되었습니다. 암로디핀 베실산염은 현재 세계적으로 가장 일반적으로 처방되는 고혈압 치료제 중 하나입니다. 암로디핀 베실산염의 인기의 원인은 다른 고혈압 치료제에 비해 부작용이 상대적으로 가볍고 장기 사용에 적합하다는 것입니다. 또한 암로디핀 베실산염은 단독요법으로도 ACE 억제제나 이뇨제 등 다른 약제와의 병용요법으로도 범용성이 있기 때문에 임상 현장에서의 유용성이 높아지고 있습니다. 또, 암로디핀 베실산염의 제네릭 의약품이 개발된 것으로, 암로디핀 베실산염의 입수가 용이해져, 가격도 저렴해진 것도, 그 보급에 기여하고 있습니다. 고혈압 및 협심증의 치료 외에도 현재 진행중인 연구는 관상 동맥 질환 및 기타 심혈관 질환의 관리에서 역할과 같은 암로디핀 베실산염의 새로운 적응 가능성을 모색하고 있습니다.

암로디핀 베실산염 시장의 성장은 여러 요인에 의해 야기됩니다. 첫째, 세계의 고혈압과 심혈관 질환의 유병률이 증가하면 효과적인 혈압제에 대한 수요가 크게 증가하고 있습니다. 둘째, 고혈압과 관련 질환에 걸리기 쉬운 세계의 인구의 고령화는 암로디핀 베실산염과 같은 치료제의 필요성을 더욱 높여줍니다. 또한, 제약 연구의 지속적인 발전으로 환자의 컴플라이언스와 치료 성과를 향상시키는 개선 된 제형과 병용 요법이 개발되었습니다. 또한 신흥 시장에서 건강 관리 인프라를 확장하면 고혈압 치료에 대한 액세스를 개선하고 시장 성장을 가속하고 있습니다. 또한 제약기업의 전략적 마케팅 활동과 교육적 노력으로 고혈압 관리에 대한 의식이 높아져 보다 많은 환자들이 치료를 받게 되고 있습니다. 마지막으로, 양호한 규제환경과 제네릭 의약품 증가로 암로디핀 베실산염은 보다 입수가 용이해지고 시장의 지속적인 성장에 기여하고 있습니다.

조사 대상 기업 예(주목의 36사)

  • Amsal Chem Pvt. Ltd.
  • Apotex Inc.
  • Cadila Pharmaceuticals Ltd.
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Midas Pharma GmbH
  • MOEHS IBERICA SL
  • Orbion Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical USA, Inc.
  • Zydus Pharmaceuticals, Inc.;

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

BJH 24.08.22

Global Amlodipine Besylate Market to Reach US$1.3 Billion by 2030

The global market for Amlodipine Besylate estimated at US$1.2 Billion in the year 2023, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. High Blood Pressure Application, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$599.8 Million by the end of the analysis period. Growth in the Heart Disease Application segment is estimated at 2.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$314.6 Million While China is Forecast to Grow at 4.3% CAGR

The Amlodipine Besylate market in the U.S. is estimated at US$314.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$261.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.5% and 1.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.0% CAGR.

Global Amlodipine Besylate Market - Key Drivers and Trends Summarized

Amlodipine is a calcium channel blocker medication primarily used to treat high blood pressure (hypertension) and angina (chest pain). By inhibiting the influx of calcium ions into cardiac and smooth muscle cells, amlodipine helps relax and widen blood vessels, improving blood flow and reducing the heart's workload. This mechanism of action makes it an effective treatment for preventing strokes, heart attacks, and other cardiovascular issues associated with hypertension. Available in various dosages, amlodipine is often prescribed as a once-daily oral tablet and can be used alone or in combination with other antihypertensive agents.

The use of amlodipine has expanded significantly since its introduction, with numerous studies validating its efficacy and safety. It is now one of the most commonly prescribed medications for managing hypertension globally. The drug's popularity is partly due to its relatively mild side effect profile compared to other antihypertensives, making it suitable for long-term use. Moreover, the versatility of amlodipine, both as a monotherapy and in combination with other medications like ACE inhibitors or diuretics, has enhanced its utility in clinical practice. The development of generic versions of amlodipine has also made it more accessible and affordable, contributing to its widespread adoption. In addition to treating hypertension and angina, ongoing research is exploring potential new indications for amlodipine, such as its role in managing coronary artery disease and other cardiovascular conditions.

The growth in the amlodipine market is driven by several factors. Firstly, the increasing prevalence of hypertension and cardiovascular diseases worldwide has significantly boosted the demand for effective antihypertensive medications. Secondly, the aging global population, which is more prone to hypertension and related disorders, has further escalated the need for treatments like amlodipine. Additionally, the continuous advancement in pharmaceutical research has led to the development of improved formulations and combination therapies that enhance patient compliance and therapeutic outcomes. The expansion of healthcare infrastructure in emerging markets has also improved access to hypertension treatments, thereby driving market growth. Furthermore, strategic marketing efforts and educational initiatives by pharmaceutical companies have raised awareness about hypertension management, encouraging more patients to seek treatment. Finally, favorable regulatory environments and the increasing availability of generic versions have made amlodipine more accessible, contributing to its sustained market growth.

Select Competitors (Total 36 Featured) -

  • Amsal Chem Pvt. Ltd.
  • Apotex Inc.
  • Cadila Pharmaceuticals Ltd.
  • Century Pharmaceuticals Ltd.
  • Changzhou Yabang Pharmaceutical Co. Ltd.
  • Cipla Ltd
  • Dr. Reddys Laboratories Ltd.
  • Lupin Pharmaceuticals, Inc.
  • Midas Pharma GmbH
  • MOEHS IBERICA SL
  • Orbion Pharmaceuticals Pvt. Ltd.
  • Pfizer Inc.
  • Strides Pharma Science Ltd
  • Teva Pharmaceutical USA, Inc.
  • Zydus Pharmaceuticals, Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Amlodipine Besylate - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Hypertension and Cardiovascular Diseases Drives Demand for Amlodipine Besylate
    • Advancements in Drug Formulation Enhance Efficacy and Patient Compliance
    • Increasing Geriatric Population Boosts Market Growth for Amlodipine Besylate
    • Growing Awareness of Hypertension Management Expands Market Opportunities
    • Development of Combination Therapies with Amlodipine Besylate Attracts Consumer Interest
    • Personalized Medicine Trends Create New Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Amlodipine Besylate Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Amlodipine Besylate by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for High Blood Pressure Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for High Blood Pressure Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Amlodipine Besylate by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Amlodipine Besylate by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • INDIA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Amlodipine Besylate by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Amlodipine Besylate by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Amlodipine Besylate by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030
  • AFRICA
    • Amlodipine Besylate Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Amlodipine Besylate by Application - High Blood Pressure Application, Heart Disease Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Amlodipine Besylate by Application - Percentage Breakdown of Value Sales for High Blood Pressure Application, Heart Disease Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제